Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters
V. Kh. Khavinson, N. S. Linkova, A. I. Rudskoy, M. G. Petukhov · 2023 · Original article; author-hosted PDF
What does this source report?
Examines transporter interactions for 26 ultrashort peptides. Feasibility at this level is not demonstrated oral bioavailability, brain delivery or clinical efficacy.
- Population and setting
- Molecular transport feasibility investigation
- Evidence type
- Not classified
- Preparation
- See the original report; formulation details require verification.
- Source language
- English
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Source-linked does not mean a completed risk-of-bias review.
- A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Title, authors and abstract checked; detailed experimental/computational methods await appraisal.
Recorded source-check date: 2026-09-27. This date does not imply a completed systematic review.
Cite and trace this record
Original source: V. Kh. Khavinson, N. S. Linkova, A. I. Rudskoy, M. G. Petukhov. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters Original article; author-hosted PDF 2023.
Molekul research summary: https://molekul.io/research/transporters-2023. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Pinealon
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.
Epitalon
AEDG was detected in pineal complex, but the long-term Epithalamin patient studies concern the extract. Synthetic-peptide effects require their own evidence.